---
title: Does Early Childhood BCG Vaccination Improve Survival to Midlife in a Population
  With a Low Tuberculosis Prevalence? Quasi-experimental Evidence on Nonspecific Effects
  From 32 Swedish Birth Cohorts
date: '2023-09-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37732832/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230921191728&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: The Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis (TB) is widely
  used globally. Many high-income countries discontinued nationwide vaccination policies
  starting in the 1980s as the TB prevalence decreased. However, there is continued
  scientific interest in whether the general childhood immunity boost conferred by
  the BCG vaccination impacts adult health and mortality in low-TB contexts (known
  as nonspecific effects). While recent studies have found evidence of an association
  ...
disable_comments: true
---
The Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis (TB) is widely used globally. Many high-income countries discontinued nationwide vaccination policies starting in the 1980s as the TB prevalence decreased. However, there is continued scientific interest in whether the general childhood immunity boost conferred by the BCG vaccination impacts adult health and mortality in low-TB contexts (known as nonspecific effects). While recent studies have found evidence of an association ...